EmbaseElsevier
|
||||||
Related Products
|
||||||
About
DrugCard is an AI-powered pharmacovigilance platform that helps pharmaceutical companies, CROs, and drug safety teams automate key PV workflows. The platform supports global and local literature monitoring, regulatory intelligence, and adverse event management, helping teams reduce manual screening, identify relevant safety information faster, and maintain audit-ready processes. DrugCard combines AI-driven article pre-assessment, summaries, translations, keyword highlighting, notifications, reporting, audit trails, and case management tools in one connected system. With coverage of 121+ countries, 2,200+ local medical sources, and 100+ languages, DrugCard is designed for MAHs, QPPVs, LQPPVs, regulatory teams, and PV professionals who need scalable, transparent, and compliant automation while keeping human experts in control of final decisions.
|
About
Improve your biomedical research with the world’s most comprehensive biomedical literature database. More biomedical evidence by searching comprehensive, relevant, and up-to-date biomedical research. Create systematic searches and automate query building using intuitive search forms. Uncover drug-disease relationships and drug-drug interactions, manually curated from deep indexing. The accelerated pace of biomedical research and development demands comprehensive information. You anticipate risk by assessing everything that is known. You track safety to meet regulations. You uncover connections to push innovations. Embase is a unique medical literature database where comprehensive goes beyond content. With Emtree indexing of full-text content and dedicated search terms, you find all relevant and current results. This includes information that may not be uncovered in other databases. Scroll down to find out why regulatory agencies recommend Embase in their best practice guidelines.
|
|||||
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
Platforms Supported
Windows
Not Supported
Mac
Not Supported
Linux
Not Supported
Cloud
Supported
On-Premises
Not Supported
iPhone
Not Supported
iPad
Not Supported
Android
Not Supported
Chromebook
Not Supported
|
|||||
Audience
Pharmacovigilance teams, Marketing Authorization Holders, CROs, QPPVs and LQPPVs, Drug Safety Officers, Regulatory Affairs teams, Pharmaceutical and biotech companies
|
Audience
Healthcare providers seeking a tool to improve their biomedical research through a biomedical literature database
|
|||||
Support
Phone Support
Not Supported
24/7 Live Support
Supported
Online
Supported
|
Support
Phone Support
Supported
24/7 Live Support
Supported
Online
Supported
|
|||||
API
Offers API
Supported
|
API
Offers API
Not Supported
|
|||||
Screenshots and Videos |
Screenshots and Videos |
|||||
Pricing
individual
Free Version
Not Supported
Free Trial
Supported
|
Pricing
No information available.
Free Version
Not Supported
Free Trial
Not Supported
|
|||||
Reviews/
|
Reviews/
|
|||||
Training
Documentation
Supported
Webinars
Not Supported
Live Online
Supported
In Person
Supported
|
Training
Documentation
Supported
Webinars
Supported
Live Online
Supported
In Person
Not Supported
|
|||||
Company InformationDrugCard
Founded: 2021
Estonia
drug-card.io
|
Company InformationElsevier
Netherlands
www.embase.com/landing
|
|||||
Alternatives |
Alternatives |
|||||
|
|
||||||
|
|
|
|||||
Categories |
Categories |
|||||
Integrations
CoVigilAI
Not Supported
|
||||||
|
|
|